| 英文名稱(chēng) | Crizotinib (PF-02341066) |
|---|---|
| 中文名稱(chēng) | 克唑替尼 |
| CAS號(hào) | 877399-52-5 |
| 分子式 | C21H22Cl2FN5O |
| 分子量 | 450.34 |
| 外觀 | White to light brown powder |
| 儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| 規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 |
|---|---|---|---|---|
| 50 mg | 3-5days | ¥450.00 | 登錄后可見(jiàn) | |
| 100 mg | 3-5days | ¥720.00 | 登錄后可見(jiàn) | |
| 250 mg | 3-5days | ¥1152.00 | 登錄后可見(jiàn) |
| 英文名稱(chēng) | Crizotinib (PF-02341066) |
|---|---|
| 中文名稱(chēng) | 克唑替尼 |
| CAS號(hào) | 877399-52-5 |
| 分子式 | C21H22Cl2FN5O |
| 分子量 | 450.34 |
| 外觀 | White to light brown powder |
| 儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Crizotinib (formerly known as PF-02341066; trade name: Xalkori) is a potent, orally bioavailable small molecule inhibitor of c-Met and ALK that is bioavailable when taken orally. In assays based on cells, it inhibits c-Met and ALK with IC50 values of 11 nM and 24 nM, respectively.